Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H12N2O.C4H6O6 |
| Molecular Weight | 326.3019 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@H]([C@@H](O)C(O)=O)C(O)=O.CN1[C@@H](CCC1=O)C2=CN=CC=C2
InChI
InChIKey=NNGHNRKZQZZELM-NDAAPVSOSA-N
InChI=1S/C10H12N2O.C4H6O6/c1-12-9(4-5-10(12)13)8-3-2-6-11-7-8;5-1(3(7)8)2(6)4(9)10/h2-3,6-7,9H,4-5H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t9-;1-,2-/m01/s1
| Molecular Formula | C4H6O6 |
| Molecular Weight | 150.0868 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C10H12N2O |
| Molecular Weight | 176.2151 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: description was created based on several sources, including:
https://cancercontrol.cancer.gov/brp/tcrb/monographs/7/m7_7.pdf | https://www.ncbi.nlm.nih.gov/pubmed/26972290
Curator's Comment: description was created based on several sources, including:
https://cancercontrol.cancer.gov/brp/tcrb/monographs/7/m7_7.pdf | https://www.ncbi.nlm.nih.gov/pubmed/26972290
Cotinine is a product formed after the chemical nicotine enters the body. Measuring cotinine in people’s blood is the most reliable way to determine exposure to nicotine for both smokers and nonsmokers exposed to environmental tobacco smoke. Cotinine is safe, non-addictive and has pharmacokinetic properties adequate for therapeutic use. Research has shown that cotinine has antipsychotic, anxiolytic, and antidepressant properties and modulates the serotonergic, cholinergic and dopaminergic systems. Cotinine behaves as a positive allosteric modulator of the nicotinic acetylcholine receptors and has anti-inflammatory effects. Cotinine is under investigation as an agent for the treatment of depression, PTSD, schizophrenia, Alzheimer's disease and Parkinson's disease.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Nicotinic acetylcholine receptors alpha3/alpha6/beta2 (Saimiri sciureus) |
236.0 µM [EC50] | ||
Target ID: Nicotinic acetylcholine receptors alpha4/beta2 (Saimiri sciureus) |
495.0 µM [EC50] | ||
Target ID: CHEMBL2492 |
175.0 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | Unknown Approved UseUnknown |
|||
| Diagnostic | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Urine test for the assessment of smoking status. | 2001 |
|
| The concentration of three anti-seizure medications in hair: the effects of hair color, controlling for dose and age. | 2001 |
|
| Determination of coumarin metabolism in Turkish population. | 2001 Apr |
|
| Accuracy of self-reported cigarette smoking among pregnant women in the 1990s. | 2001 Apr |
|
| Infant exposure to environmental tobacco smoke: a prevalence study in Australia. | 2001 Apr |
|
| Rebuttal to: Passive smoking adversely affects the haemostasis/fibrinolytic parameters in healthy non-smoker offspring of healthy smokers. | 2001 Apr |
|
| Effectiveness of a high school smoking cessation program. | 2001 Apr |
|
| [An appreciation of maternal smoking with high-performance liquid chromatographic determination of maternal and neonatal urinary cotinine]. | 2001 Apr |
|
| Cigarette smoking, salivary/gingival crevicular fluid cotinine and periodontal status. A 10-year longitudinal study. | 2001 Apr |
|
| Novel liquid chromatographic-tandem mass spectrometric methods using silica columns and aqueous-organic mobile phases for quantitative analysis of polar ionic analytes in biological fluids. | 2001 Apr 25 |
|
| Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion. | 2001 Aug 1 |
|
| Smoking reduction in smokers compliant to a smoking cessation trial with nicotine patch. | 2001 Feb |
|
| Assessment of prenatal smoke exposure by determining nicotine and its metabolites in maternal and neonatal urine. | 2001 Jan |
|
| High-performance liquid chromatographic determination of pyridostigmine bromide, nicotine, and their metabolites in rat plasma and urine. | 2001 Jul |
|
| A simple high-pressure liquid chromatography cotinine assay: validation of smoking status in pregnant women. | 2001 Jul |
|
| Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender. | 2001 Jul |
|
| Oltipraz chemoprevention trial in Qidong, People's Republic of China: results of urine genotoxicity assays as related to smoking habits. | 2001 Jul |
|
| Saliva cotinine as indicator of cigarette smoking in pregnant women. | 2001 Jul |
|
| Trends in the smoking habits of young adults with diabetes. | 2001 Jul |
|
| Prevalence of nicotine consumption in drug deaths. | 2001 Jul 15 |
|
| Nicotine produces selective degeneration in the medial habenula and fasciculus retroflexus. | 2001 Jul 6 |
|
| An integrated approach to prenatal smoking cessation interventions. | 2001 Jul-Aug |
|
| Nicotine metabolism and CYP2A6 allele frequencies in Koreans. | 2001 Jun |
|
| Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers. | 2001 Jun |
|
| Individual differences in urinary cotinine levels in Japanese smokers: relation to genetic polymorphism of drug-metabolizing enzymes. | 2001 Jun |
|
| Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposures in paired maternal and newborn blood samples as a measure of differential susceptibility. | 2001 Jun |
|
| Dose-years as an improved index of cumulative tobacco smoke exposure. | 2001 Jun |
|
| Heavily smoking women who cannot quit in pregnancy: evidence of pharmacokinetic predisposition. | 2001 Jun |
|
| CYP1B1 expression in human lung. | 2001 Jun |
|
| Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. | 2001 Jun |
|
| Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. | 2001 Jun |
|
| Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. | 2001 Jun 1 |
|
| Quantification of nicotine, chlorpyrifos and their metabolites in rat plasma and urine using high-performance liquid chromatography. | 2001 Jun 15 |
|
| A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women. | 2001 Jun 15 |
|
| Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. | 2001 Jun 2 |
|
| Smoking related to plasma leptin concentration in pregnant women and their newborn infants. | 2001 Mar |
|
| Exposure to ethanol and nicotine during the brain growth spurt: spatial DMP performance in male rats. | 2001 Mar |
|
| CDC unveils body burden. | 2001 May |
|
| Household smoking and bronchial hyperresponsiveness in children with asthma. | 2001 May |
|
| Effects of smoking cessation and nicotine substitution on systemic eicosanoid production in man. | 2001 May |
|
| Preparation of pyridine-N-glucuronides of tobacco-specific nitrosamines. | 2001 May |
|
| Science is changing! 300 chemicals and each chemical will have a fingerprint. | 2001 May |
|
| Metropolitan home living conditions associated with indoor endotoxin levels. | 2001 May |
|
| Adaptation of an enzyme immunoassay to assess urinary cotinine in nonsmokers exposed to tobacco smoke. | 2001 May |
|
| Measures of maternal tobacco exposure and infant birth weight at term. | 2001 May 15 |
|
| Drop in cotinine levels signals less smoke exposure, experts say. | 2001 May 2 |
|
| Bacterial mutagenicity of some tobacco aromatic nitrogen bases and their mixtures. | 2001 May 31 |
|
| In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. | 2001 May 4 |
|
| Systemic nicotine exposure in tobacco harvesters. | 2001 May-Jun |
|
| Personal exposures to PM(2.5) and polycyclic aromatic hydrocarbons and their relationship to environmental tobacco smoke at two locations in Greece. | 2001 May-Jun |
Sample Use Guides
High (190 ug/ml) concentration of Cotinine significantly altered all the sperm kinetic variables in relation to the time of incubation (forward motility, velocity, linearity and beat cross-frequency). Despite the impact seen on these parameters, there was still 30% forward motility after 24 h of incubation.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Jul 05 23:19:14 UTC 2023
by
admin
on
Wed Jul 05 23:19:14 UTC 2023
|
| Record UNII |
FQ7X51Z02G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4315-41-7
Created by
admin on Wed Jul 05 23:19:14 UTC 2023 , Edited by admin on Wed Jul 05 23:19:14 UTC 2023
|
PRIMARY | |||
|
FQ7X51Z02G
Created by
admin on Wed Jul 05 23:19:14 UTC 2023 , Edited by admin on Wed Jul 05 23:19:14 UTC 2023
|
PRIMARY | |||
|
91826822
Created by
admin on Wed Jul 05 23:19:14 UTC 2023 , Edited by admin on Wed Jul 05 23:19:14 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |